PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2159394

[Drugs interfering with platelet function].

A Marino·G De Natale
View original source ↗Export metadata ↓

Abstract

Drugs interfering with platelet aggregation pathways and Ca2+ availability were reviewed. Particularly receptor antagonists, drugs affecting intracellular concentration of cAMP and drugs acting on enzymes involved in the synthesis of PGE2 and PGF2, thromboxane and PGI, were considered.

Explore related subjects

Blood Coagulation FactorsBlood PlateletsCalciumCyclic AMPPlatelet Activating FactorPlatelet AggregationPlatelet Aggregation InhibitorsProstaglandinsReceptors, Cell SurfaceEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Marino, G De Natale. 1990-02-15. [Drugs interfering with platelet function].. https://pubmed.ncbi.nlm.nih.gov/2159394/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.

Platelet clots resist fibrinolysis by plasminogen activators. We hypothesized that platelet factor XIII may enhance the fibrinolytic resistance of platelet-rich clots by catalyzing the crosslinking of alpha 2-antiplasmin (alpha 2AP) to fibrin. Analysis of plasma clot structure by polyacrylamide gel electrophoresis and immunoblotting revealed accelerated alpha 2AP-fibrin crosslinking in platelet-rich compared with platelet-depleted plasma clots. A similar study of clots formed with purified fibrinogen (depleted of factor XIII activity), isolated platelets, and specific factor XIII inhibitors indicated that this accelerated crosslinking was due to the catalytic activity of platelet factor XIII. Moreover, when washed platelets were aggregated by thrombin, there was evidence of platelet factor XIII-mediated crosslinking between platelet alpha 2AP and platelet fibrin(ogen). Specific inhibition (by a monoclonal antibody) of the alpha 2AP associated with washed platelet aggregates accelerated the fibrinolysis of the platelet aggregate. Thus in platelet-rich plasma clots, and in thrombin-induced platelet aggregates, platelet factor XIII actively formed alpha 2AP-fibrin crosslinks, which appeared to enhance the resistance of platelet-rich clots to fibrinolysis.

Blood Coagulation Factors↗